| scholarly article | Q13442814 |
| P50 | author | Lawrence Corey | Q6503944 |
| Robert W Coombs | Q98719827 | ||
| P2093 | author name string | Nelson Fausto | |
| Ming Chang | |||
| David R Gretch | |||
| Weiliang Tang | |||
| Daniel G Sullivan | |||
| Jean Campbell | |||
| Catherine A Lázaro | |||
| P2860 | cites work | Binding of hepatitis C virus to CD81 | Q22004178 |
| Viral and therapeutic control of IFN-beta promoter stimulator 1 during hepatitis C virus infection | Q24546318 | ||
| Inhibition of dsRNA-induced signaling in hepatitis C virus-infected cells by NS3 protease-dependent and -independent mechanisms | Q24548483 | ||
| Characterization of soluble hepatitis C virus RNA-dependent RNA polymerase expressed in Escherichia coli | Q27469346 | ||
| Long-term follow-up of chimpanzees inoculated with the first infectious clone for hepatitis C virus | Q27469355 | ||
| Lambda interferon inhibits hepatitis B and C virus replication | Q27469456 | ||
| In situ distribution of hepatitis C virus replicative-intermediate RNA in hepatic tissue and its correlation with liver disease | Q27469626 | ||
| Mutations in Hepatitis C Virus RNAs Conferring Cell Culture Adaptation | Q27469769 | ||
| Terminal nucleotidyl transferase activity of recombinant Flaviviridae RNA-dependent RNA polymerases: implication for viral RNA synthesis | Q27469965 | ||
| Robust hepatitis C virus infection in vitro | Q27470013 | ||
| Persistent and transient replication of full-length hepatitis C virus genomes in cell culture | Q27472869 | ||
| Production of infectious genotype 1a hepatitis C virus (Hutchinson strain) in cultured human hepatoma cells | Q27473106 | ||
| Construction and characterization of infectious intragenotypic and intergenotypic hepatitis C virus chimeras | Q27473179 | ||
| Efficient Replication of Hepatitis C Virus Genotype 1a RNAs in Cell Culture | Q27473339 | ||
| Cell culture-grown hepatitis C virus is infectious in vivo and can be recultured in vitro | Q27473436 | ||
| Biochemical properties of hepatitis C virus NS5B RNA-dependent RNA polymerase and identification of amino acid sequence motifs essential for enzymatic activity | Q27480890 | ||
| Transmission of hepatitis C by intrahepatic inoculation with transcribed RNA | Q27860484 | ||
| Efficient initiation of HCV RNA replication in cell culture | Q27860520 | ||
| Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line | Q27860561 | ||
| Production of infectious hepatitis C virus in tissue culture from a cloned viral genome | Q27860899 | ||
| Complete replication of hepatitis C virus in cell culture | Q27860934 | ||
| CD81 is an entry coreceptor for hepatitis C virus | Q29614812 | ||
| Epidemiology of hepatitis C: geographic differences and temporal trends | Q29615896 | ||
| Evasion of intracellular host defence by hepatitis C virus | Q29618976 | ||
| Efficient replication of the genotype 2a hepatitis C virus subgenomic replicon | Q29619491 | ||
| Systems to culture hepatitis C virus. | Q33791647 | ||
| Hepatitis C virus infection in the United States | Q33809474 | ||
| Distinct poly(I-C) and virus-activated signaling pathways leading to interferon-beta production in hepatocytes | Q34398825 | ||
| Isolation of multipotent progenitor cells from human fetal liver capable of differentiating into liver and mesenchymal lineages | Q34773026 | ||
| Hepatitis C virus comes full circle: production of recombinant infectious virus in tissue culture | Q36326835 | ||
| Evidence for in vitro replication of hepatitis C virus genome in a human T-cell line | Q37061606 | ||
| De novo initiation pocket mutations have multiple effects on hepatitis C virus RNA-dependent RNA polymerase activities | Q37596636 | ||
| Nonhepatic cell lines HeLa and 293 support efficient replication of the hepatitis C virus genotype 2a subgenomic replicon. | Q40481063 | ||
| Genotype 2a hepatitis C virus subgenomic replicon can replicate in HepG2 and IMY-N9 cells | Q40584675 | ||
| Mutations in the NS5A gene of hepatitis C virus in North American patients infected with HCV genotype 1a or 1b. | Q42985033 | ||
| Molecular characterization and dynamics of hepatitis C virus replication in human fetal hepatocytes infected in vitro | Q42985381 | ||
| Detection of widespread hepatocyte infection in chronic hepatitis C. | Q42989422 | ||
| Generation of transmissible hepatitis C virions from a molecular clone in chimpanzees | Q42992662 | ||
| Permissiveness of human biliary epithelial cells to infection by hepatitis C virus | Q42993187 | ||
| Fluctuation patterns of HCV-RNA serum level in patients with chronic hepatitis C. | Q42998102 | ||
| Epidemiology of hepatitis C in the United States. | Q50656203 | ||
| Cell lines from non-neoplastic liver and hepatocellular carcinoma tissue from a single patient. | Q53455996 | ||
| Establishment, characterization, and long-term maintenance of cultures of human fetal hepatocytes. | Q54128063 | ||
| Natural history of hepatitis C | Q73398834 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | virology | Q7215 |
| Hepatitis C virus | Q708693 | ||
| hepatitis C | Q154869 | ||
| P304 | page(s) | 478-89 | |
| P577 | publication date | 2007-02-01 | |
| P1433 | published in | The American Journal of Pathology | Q4744259 |
| P1476 | title | Hepatitis C Virus Replication in Transfected and Serum-Infected Cultured Human Fetal Hepatocytes | |
| P478 | volume | 170 |
| Q90975060 | A murine model demonstrating reversal of structural and functional correlates of cirrhosis with progenitor cell transplantation |
| Q37798816 | Advances and challenges in studying hepatitis C virus in its native environment |
| Q26851652 | Advances in experimental systems to study hepatitis C virus in vitro and in vivo |
| Q27491321 | An Implantable Vascularized Protein Gel Construct That Supports Human Fetal Hepatoblast Survival and Infection by Hepatitis C Virus in Mice |
| Q36425910 | Antitumor activity of type I and type III interferons in BNL hepatoma model |
| Q34273110 | Are all cancer stem cells created equal? |
| Q27488358 | CD56+ T cells inhibit hepatitis C virus replication in human hepatocytes |
| Q36793453 | Cancer stem cells in the development of liver cancer |
| Q42609571 | Development of persistent HCV genotype 3a infection cell culture model in huh-7 cell |
| Q39543313 | Down-regulation of IRES containing 5'UTR of HCV genotype 3a using siRNAs. |
| Q39526744 | Effect of combined siRNA of HCV E2 gene and HCV receptors against HCV. |
| Q42425281 | Efficiency of hepatitis C virus infection in vitro |
| Q37235541 | Emerging therapies for hepatitis C and HIV in drug abusers: drugs and strategies |
| Q38046287 | Entry and replication of recombinant hepatitis C viruses in cell culture |
| Q39670501 | Expression of paramyxovirus V proteins promotes replication and spread of hepatitis C virus in cultures of primary human fetal liver cells |
| Q48100807 | Germline genetic variants with implications for disease risk and therapeutic outcomes |
| Q38557431 | HCV entry receptors as potential targets for siRNA-based inhibition of HCV. |
| Q27485023 | Hepatitis C Virus Infection Induces the Beta Interferon Signaling Pathway in Immortalized Human Hepatocytes |
| Q35560734 | Hepatitis C virus induces interferon-λ and interferon-stimulated genes in primary liver cultures |
| Q35531664 | Hepatitis C virus-induced cancer stem cell-like signatures in cell culture and murine tumor xenografts |
| Q37917252 | IFN-λs |
| Q39092410 | In vitro neutralization of HCV by goat antibodies against peptides encompassing regions downstream of HVR-1 of E2 glycoprotein. |
| Q41887493 | In vitro systems for the study of hepatitis C virus infection |
| Q34870944 | In-vitro model systems to study Hepatitis C Virus |
| Q35587088 | Inhibition of HCV 3a genotype entry through host CD81 and HCV E2 antibodies |
| Q34351097 | Inhibition of core gene of HCV 3a genotype using synthetic and vector derived siRNAs |
| Q34980601 | Inhibition of full length hepatitis C virus particles of 1a genotype through small interference RNA |
| Q39619568 | Inhibition of hepatitis C virus genotype 3a by siRNAs targeting envelope genes. |
| Q21296797 | Interferon lambda: a new sword in cancer immunotherapy |
| Q34433087 | Interferon lambda: opportunities, risks, and uncertainties in the fight against HCV. |
| Q38974225 | Lambda Interferons: New Cytokines with Old Functions |
| Q47901105 | Long-Term Fate of Human Fetal Liver Progenitor Cells Transplanted in Injured Mouse Livers. |
| Q37125615 | Medical consequences of drug abuse and co-occurring infections: research at the National Institute on Drug Abuse |
| Q35787014 | Modeling hepatitis C virus infection using human induced pluripotent stem cells |
| Q42999438 | New Cell Culture Models of Hepatitis C Virus Entry, Replication, and Virus Production |
| Q33746198 | Osteopontin is up-regulated in chronic hepatitis C and is associated with cellular permissiveness for hepatitis C virus replication |
| Q27491284 | Persistent hepatitis C virus infection in microscale primary human hepatocyte cultures |
| Q36960064 | Potential role of RNAi in the treatment of HCV infection |
| Q37352203 | Primary hepatocytes as targets for hepatitis C virus replication |
| Q36933791 | Recent contributions of in vitro models to our understanding of hepatitis C virus life cycle |
| Q27482327 | Responses of Nontransformed Human Hepatocytes to Conditional Expression of Full-Length Hepatitis C Virus Open Reading Frame |
| Q34832969 | Role of HCV Core gene of genotype 1a and 3a and host gene Cox-2 in HCV-induced pathogenesis. |
| Q39791492 | SOCS3 and IRS-1 gene expression differs between genotype 1 and genotype 2 hepatitis C virus-infected HepG2 cells |
| Q38404573 | The application of engineered liver tissues for novel drug discovery |
| Q33360674 | The missing pieces of the HCV entry puzzle |
Search more.